Transgender people are at high risk for HIV, but too little is known about prevention and treatment for this population
START study shows that people starting HIV treatment earlier have better quality of life
Maraviroc may work as PrEP in combination with another drug – but probably not by itself
Rate of entry into HIV care improved by personalised counselling
Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy
Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption
Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people
Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016
Early antiretroviral therapy reduces the risk of infection-related cancers
